SLI
TEVA icon

Sumitomo Life Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

Sumitomo Life Insurance’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-27,861
Closed -$894K – 287
2017
Q1 		$894K Sell
27,861
-1,729
-6% -$59K 0.13% 228
2016
Q4 		$1.07M Sell
29,590
-2,404
-8% -$96K 0.15% 215
2016
Q3 		$1.47M Sell
31,994
-3,955
-11% -$206K 0.22% 157
2016
Q2 		$1.81M Sell
35,949
-2,030
-5% -$108K 0.25% 139
2016
Q1 		$2.03M Buy
37,979
+3,416
+10% +$200K 0.26% 126
2015
Q4 		$2.27M Sell
34,563
-814
-2% -$50.3K 0.29% 116
2015
Q3 		$2M Sell
35,377
-900
-2% -$58.4K 0.27% 123
2015
Q2 		$2.14M Buy
36,277
+4,453
+14% +$275K 0.26% 127
2015
Q1 		$1.98M Sell
31,824
-3,368
-10% -$196K 0.22% 165
2014
Q4 		$2.02M Sell
35,192
-1,988
-5% -$111K 0.2% 186
2014
Q3 		$2M Sell
37,180
-979
-3% -$51.9K 0.2% 194
2014
Q2 		$2M Buy
+38,159
New +$1.95M 0.19% 194
2013
Q4 		– Sell
-55,351
Closed -$2.09M – 267
2013
Q3 		$2.09M Sell
55,351
-2,027
-4% -$79.1K 0.19% 190
2013
Q2 		$2.25M Buy
+57,378
New +$2.23M 0.22% 182

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Life Insurance's TEVA Position: Q2 2017 in Review

Sumitomo Life Insurance sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 27,861 shares — an estimated $894K sold.

Sumitomo Life Insurance first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $2.27M in Q4 2015. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Sumitomo Life Insurance reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Sumitomo Life Insurance sold 27,861 Teva Pharmaceuticals shares in Q2 2017, an estimated $894K.
  • Sumitomo Life Insurance first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Sumitomo Life Insurance's Teva Pharmaceuticals position peaked at $2.27M in Q4 2015.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Sumitomo Life Insurance's 13F filing for Q2 2017, filed 27 Jul 2017.